Pfizer and Moderna made life-saving antibodies. So for what reason are their stocks disintegrating?
Pfizer, BioNTech and Moderna are encountering a post-immunization headache on Wall Street this year. Each of the three stocks flooded tremendously in 2021, on account of their Covid-19 antibodies’ prosperity and solid deals. In any case, 2022 hasn’t been as kind to them. Portions of Pfizer (PFE) are down around 15%, while its Comirnaty immunization … Read more